£495.00

It has never been this cheap. We have no record of a lower price.

£495 today · cheaper than every other day in the last 3 months

The 2023-2028 Outlook for Multiple Myeloma Therapeutics in Japan

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 20 days · 20 data points (no recent data)

Historical
Generating forecast…
£495.00 £470.25 £480.15 £490.05 £499.95 £509.85 £519.75 26 July 2026 30 July 2026 04 August 2026 09 August 2026 14 August 2026
View at Amazon ↗

Price data last checked 71 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 20 days • 1 price levels

Days at Price
20 days 0 5 10 15 20 £495 Days at Price

Price Analysis

Most common price: £495 (20 days, 100.0%)

Price range: £495 - £495

Price levels: 1 different prices over 20 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
28 November 2022
Listed Since
08 December 2022

Similar Products You Might Like

The 2023-2028 Outlook for Multiple Myeloma Treatments in Japan
99% match

The 2023-2028 Outlook for Multiple Myeloma Treatments in Japan

£495.00 20 Aug 2026
The 2023-2028 Outlook for Multiple Myeloma Treatments in China
99% match

The 2023-2028 Outlook for Multiple Myeloma Treatments in China

£495.00 22 Aug 2026
The 2013-2018 Outlook for Multiple Myeloma Therapeutics in Africa
99% match

The 2013-2018 Outlook for Multiple Myeloma Therapeutics in Africa

£325.00 03 Sep 2026
The 2025-2030 World Outlook for Chemotherapy and Other Multiple Myeloma Therapeutics
98% match

The 2025-2030 World Outlook for Chemotherapy and Other Multiple Myeloma Therapeutics

Price unavailable
The 2023-2028 Outlook for Chronic Myelogenous Leukemia Treatments for US Zip Codes
97% match

The 2023-2028 Outlook for Chronic Myelogenous Leukemia Treatments for US Zip Codes

£490.00 28 Aug 2026
The 2016-2021 Outlook for Hematology and Oncology Products in Europe
97% match

The 2016-2021 Outlook for Hematology and Oncology Products in Europe

£425.00 20 Aug 2026
The 2016-2021 Outlook for Hematology and Oncology Products in Asia
97% match

The 2016-2021 Outlook for Hematology and Oncology Products in Asia

£425.00 20 Aug 2026
The 2016-2021 Outlook for Hematology and Oncology Products in North America & the Caribbean
97% match

The 2016-2021 Outlook for Hematology and Oncology Products in North America & the Caribbean

£425.00 20 Aug 2026
The 2016-2021 Outlook for Hematology and Oncology Products in Japan
97% match

The 2016-2021 Outlook for Hematology and Oncology Products in Japan

£595.00 21 Aug 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in Japan
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in Japan

£495.00 19 Aug 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in Japan
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in Japan

£495.00 22 Aug 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in Japan
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in Japan

£495.00 25 Aug 2026
The 2021-2026 World Outlook for Hematology and Oncology Products
97% match

The 2021-2026 World Outlook for Hematology and Oncology Products

£795.00 20 Aug 2026
The 2013-2018 Outlook for Lymphoma Therapeutics in Africa
97% match

The 2013-2018 Outlook for Lymphoma Therapeutics in Africa

£325.00 03 Sep 2026
The 2016-2021 Outlook for Hematology and Oncology Products in India
97% match

The 2016-2021 Outlook for Hematology and Oncology Products in India

£595.00 22 Aug 2026
The 2016-2021 Outlook for Hematology and Oncology Products in the Middle East
97% match

The 2016-2021 Outlook for Hematology and Oncology Products in the Middle East

£425.00 21 Aug 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in China
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in China

£495.00 02 Oct 2026
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in Japan
97% match

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in Japan

£495.00 21 Aug 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in China
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in China

£495.00 18 Aug 2026
The 2016-2021 Outlook for Hematology and Oncology Products in the United States
97% match

The 2016-2021 Outlook for Hematology and Oncology Products in the United States

£595.00 18 Sep 2026
The 2016-2021 Outlook for Hematology and Oncology Products in Africa
97% match

The 2016-2021 Outlook for Hematology and Oncology Products in Africa

£425.00 21 Aug 2026
The 2016-2021 Outlook for Hematology and Oncology Products in Greater China
97% match

The 2016-2021 Outlook for Hematology and Oncology Products in Greater China

£595.00 01 Oct 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in India
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in India

£515.00 15 Aug 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in Japan
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in Japan

£495.00 26 Sep 2026